cysteine has been researched along with dalcetrapib in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Maeda, K; Okamoto, H; Shinkai, H; Uchida, I; Yamasaki, T | 1 |
Gradisar, H; Iñigo Pestaña, M; Jerala, R; Mancek-Keber, M; Martinez de Tejada, G | 1 |
2 other study(ies) available for cysteine and dalcetrapib
Article | Year |
---|---|
bis(2-(Acylamino)phenyl) disulfides, 2-(acylamino)benzenethiols, and S-(2-(acylamino)phenyl) alkanethioates as novel inhibitors of cholesteryl ester transfer protein.
Topics: Administration, Oral; Amides; Animals; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cysteine; Disulfides; Esters; Glycoproteins; Humans; Male; Rabbits; Structure-Activity Relationship; Sulfhydryl Compounds | 2000 |
Free thiol group of MD-2 as the target for inhibition of the lipopolysaccharide-induced cell activation.
Topics: Amides; Animals; Auranofin; Binding Sites; Cell Line; Cysteine; Dose-Response Relationship, Drug; Esters; Female; Humans; Lipopolysaccharides; Lymphocyte Antigen 96; Maleimides; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Structure; Protein Binding; Protein Structure, Tertiary; Pyrenes; Signal Transduction; Sulfhydryl Compounds; Toll-Like Receptors; Tumor Necrosis Factor-alpha | 2009 |